Eye Diseases "Treated" With Interoperable Medical Informatics

The overarching goal of EyeMatics is to promote an interoperable, sustainable infrastructure for the integration and sharing of data from clinical research to improve personalized medicine in ophthalmology. To achieve this, EyeMatics bundles the expertise and preliminary work of the four consortia of the Medical Informatics Initiative (MII) and the ophthalmological centers of excellence in Germany. The perspective and concerns of patients will be strongly incorporated into the project work through close cooperation with patient representatives and the inclusion of patient feedback on quality of life and treatment success. EyeMatics aims to improve the understanding of the therapeutic success of eye diseases that are usually treated with intravitreal surgical medication (IVOM). To this end, an exemplary analysis platform for "real" clinical data will be provided and a dashboard for data visualization and analysis will be developed as a web application. The dashboard is to be introduced at all participating hospital sites for research purposes.

NCT Number	NCT06810011
Lead Sponsor	University Hospital Muenster Collaborators: University Medicine Greifswald, University Medical Center Mainz, University Hospital, Aachen, Klinikum Chemnitz gGmbH, Technische Universität Dresden, University of Leipzig, University Hospital Tuebingen, Deutsche Ophthalmologische Gesellschaft e.V., Pro Retina Deutschland e.V.
Conditions	Intravitreal Injections
Enrollment	2,000 participants
Start Date	2024-03-01
Primary Completion	2028-02-29 (estimated)
Study Completion	2028-02-29 (estimated)
Updated on ClinicalTrials.gov	2025-02-05